Zantac / Ranitidine (NDMA Cancer) Statistics in Baltimore
~2.9 million
Baltimore Metro Population
~350
Est. Annual Bladder Cancer Diagnoses (Baltimore MSA)
3 years from discovery (favorable — Daubert standard)
MD SOL
Major federal agency hub (SSA, CMS, FDA) — comprehensive federal employee pharmacy records
Federal Employment
Courts in Baltimore, Maryland
Baltimore City Circuit Court
111 N Calvert St, Baltimore, MD 21202
U.S. District Court, District of Maryland — Baltimore Division
101 W Lombard St, Baltimore, MD 21201
Hospitals & Trauma Centers in Baltimore
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
401 N Broadway, Baltimore, MD 21231
University of Maryland Greenebaum Comprehensive Cancer Center
22 S Greene St, Baltimore, MD 21201
Liability Considerations in Baltimore
Zantac Litigation in Baltimore
Baltimore is home to two of the nation's premier NCI-designated cancer centers — Johns Hopkins Sidney Kimmel and UMD Greenebaum — providing world-class documentation of cancer diagnoses critical to Zantac claims. Maryland's 3-year SOL is more favorable than most states. Maryland applies Daubert under Md. R. Evid. 5-702. Baltimore's large federal workforce also means many claimants have detailed federal employee prescription records through FEHB pharmacy plans. The federal Zantac MDL (No. 2924, S.D. Florida) was largely dismissed in 2022 after Judge Robin Rosenberg excluded plaintiffs' causation experts under Daubert. However, the Delaware Superior Court under Judge Vivian Medinilla continues to actively hear Zantac cases and has allowed causation experts to proceed. Defendants Sanofi, Boehringer Ingelheim, GSK, and Pfizer are all actively litigating in Delaware. For most claimants, filing in Delaware Superior Court through national plaintiffs' counsel is now the primary path forward.
Resources for Baltimore Zantac Claimants
Baltimore-area Zantac claimants should gather pharmacy records from Rite Aid, CVS, Walgreens, and federal employee health plan pharmacy records (FEHB). Johns Hopkins and UMD Greenebaum cancer records documenting bladder, esophageal, stomach, or colorectal cancer are critical evidence. Maryland's 3-year SOL provides additional time compared to most states — but prompt consultation with qualified Zantac plaintiffs' counsel is still essential.